AMERIPRISE FINANCIAL INC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 152 filers reported holding ANI PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 9.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,364,799
+3.5%
247,413
-4.1%
0.01%
+25.0%
Q2 2023$13,883,403
+15.9%
257,912
-14.5%
0.00%0.0%
Q1 2023$11,978,161
-1.3%
301,565
-0.0%
0.00%0.0%
Q4 2022$12,133,000
+23.3%
301,595
-1.5%
0.00%0.0%
Q3 2022$9,842,000
+9.3%
306,210
+0.9%
0.00%
+33.3%
Q2 2022$9,005,000
+2.2%
303,508
-3.2%
0.00%0.0%
Q1 2022$8,813,000
-32.4%
313,473
+10.7%
0.00%
-25.0%
Q4 2021$13,045,000
+45.1%
283,077
+3.3%
0.00%
+33.3%
Q3 2021$8,992,000
-6.8%
273,945
-0.5%
0.00%0.0%
Q2 2021$9,649,000
+9.7%
275,267
+13.1%
0.00%0.0%
Q1 2021$8,795,000
+29.6%
243,333
+4.1%
0.00%
+50.0%
Q4 2020$6,785,000
+15.2%
233,646
+11.9%
0.00%0.0%
Q3 2020$5,890,000
+240.1%
208,773
+289.8%
0.00%
+100.0%
Q2 2020$1,732,000
-25.0%
53,565
-5.4%
0.00%0.0%
Q1 2020$2,308,000
-32.1%
56,643
+2.8%
0.00%0.0%
Q4 2019$3,400,000
-18.8%
55,127
-4.1%
0.00%
-50.0%
Q3 2019$4,187,000
-54.6%
57,458
-48.8%
0.00%
-50.0%
Q2 2019$9,227,000
+11.4%
112,261
-4.4%
0.00%0.0%
Q1 2019$8,281,000
+36.7%
117,391
-12.8%
0.00%
+33.3%
Q4 2018$6,058,000
-23.8%
134,563
-4.3%
0.00%0.0%
Q3 2018$7,952,000
+43.2%
140,658
+69.2%
0.00%
+50.0%
Q2 2018$5,552,000
+75.9%
83,125
+53.3%
0.00%
+100.0%
Q1 2018$3,157,000
-7.7%
54,229
+2.2%
0.00%
-50.0%
Q4 2017$3,419,000
+21.2%
53,045
-1.3%
0.00%
+100.0%
Q3 2017$2,821,000
+11.2%
53,760
-0.8%
0.00%0.0%
Q2 2017$2,536,000
-4.9%
54,205
+0.6%
0.00%0.0%
Q1 2017$2,667,000
-16.8%
53,865
+1.9%
0.00%
-50.0%
Q4 2016$3,204,000
-6.6%
52,865
+2.2%
0.00%0.0%
Q3 2016$3,431,000
+25.8%
51,712
+5.8%
0.00%0.0%
Q2 2016$2,728,000
+88.8%
48,885
+13.8%
0.00%
+100.0%
Q1 2016$1,445,000
-22.1%
42,960
+4.6%
0.00%0.0%
Q4 2015$1,854,000
-26.8%
41,080
-35.9%
0.00%
-50.0%
Q3 2015$2,533,000
-38.7%
64,110
-3.8%
0.00%0.0%
Q2 2015$4,134,000
+4.3%
66,637
+5.2%
0.00%0.0%
Q1 2015$3,963,000
+31.4%
63,360
+18.5%
0.00%0.0%
Q4 2014$3,015,000
+333.2%
53,465
+117.3%
0.00%
Q3 2014$696,000
+68.9%
24,605
+105.9%
0.00%
Q2 2014$412,00011,9500.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders